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A global health action agenda for the Biden administration
COVID-19 has revealed major weaknesses in the
International Health Regulations (IHR) 2005. The in
coming US administration should support IHR reforms.
In our view, the IHR must protect the confidentiality
of unofficial data sources while making credible data
public. The IHR should also empower the WHO DirectorGeneral to declare an intermediate level for public
health emergencies of international concern. Impor
tantly, we believe the IHR should more clearly define
states’ international assistance responsibilities to build
core health-system capacities.2
Another urgent issue for the incoming administration
will be to help provide equitable worldwide distri
bution of COVID-19 vaccines. The USA should join
the 189 countries participating in the COVID-19 Vaccine
Global Access (COVAX) Facility.3 COVAX aims to ensure
that 92 low-income and middle-income countries
equitably access COVID-19 vaccines.4 The USA, working
with partners, should fund the $5 billion COVAX Advance
Market Commitments5 to incentivise mass scale-up of
vaccine production and procure vaccine doses,6 along
with providing additional funds for distribution.
Vaccine nationalism is a major challenge. Even before
the full regulatory approval of any COVID-19 vaccine
candidates, confirmed purchases by individual countries
cover 6·8 billion doses, with another 2·8 billion doses
under negotiation or reserved. Low-income countries hold
no prepurchase agreements,7 and are reliant on COVAX.
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Joe Biden will assume the US presidency at a time of
unprecedented global health crises, with the COVID-19
pandemic and major setbacks in reducing poverty,
hunger, and disease. The COVID-19 pandemic offers rare
opportunities for the US President-elect to spearhead
long-overdue structural changes and revitalise global
health leadership. Building trust among global partners
will be challenging, given the USA’s withdrawal from,
and disruption of, international cooperation under the
presidency of Donald Trump. The USA will have to lead
in a different, more collaborative way.
The COVID-19 pandemic is currently the world’s
greatest challenge. The incoming administration should
mobilise partners to fund the UN COVID-19 Global
Humanitarian Response Plan (GHRP), designed to
coordinate health and economic action in vulnerable
countries. So far, the UN has received only 40% of the
US$9·5 billion GHRP goal for 2020.1 To gain high-level
political support, the Biden administration will need to
press for a UN Security Council resolution on COVID-19,
modelled on the 2014 resolution on Ebola virus disease
as a threat to peace and security.
Biden must also strengthen WHO, not only for the
response to COVID-19, but also for the full gamut
of health challenges, ranging from maternal, child,
and adolescent health to injuries, non-communicable
diseases, and universal health coverage. Addressing
health inequities will be crucial in all these domains.
WHO’s $5·8 billion biennial budget—about the size of
a large US hospital—is incommensurate with its global
mandate. WHO, moreover, controls less than a quarter
of that inadequate budget, with most funds already
earmarked. The Biden administration should coordinate
with other member states to submit a World Health
Assembly resolution doubling mandatory contributions
to WHO.
Placing WHO in the vortex of geopolitical tensions,
as has occurred during the COVID-19 pandemic, is
destructive and the USA must not cause or add to
the politicisation of WHO. Member states, including
the USA, should pledge to maintain the scientific
integrity and political neutrality of WHO. The
Biden administration can press for necessary WHO
reforms, including more inclusive governance and civil
society participation.
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COVAX has signed agreements for only 700 million
doses of COVID-19 vaccines7 of a targeted 2 billion doses
by 2021.8 President-elect Biden will need to launch
international negotiations to redistribute a substantial
portion of national COVID-19 vaccine purchases to
COVAX, while also supporting immunisation education
campaigns to increase coverage.
Beyond the pandemic itself, COVID-19 has unleashed
vast economic, social, and health crises. Disruptions
to health services because of COVID-19 might lead
to an estimated extra 1·5 million AIDS, tuberculosis,
and malaria deaths in 2020 alone.9 Child vaccination
campaigns have stalled, even as measles deaths increased
by 50% from 2016 to 2019.10 The polio eradication
campaign has also been disrupted. Maternal and child
deaths are projected to rise sharply.11 The World Food
Programme (WFP) projects a doubling of children and
adults facing acute hunger globally by the end of 2020.12
The US Congress should dedicate 2% of COVID-19
emergency relief spending to global humanitarian assis
tance.13 With lower-income countries facing crushing
debt service burdens, the incoming US administration
should support the extension of a multiyear debt service
moratorium for these countries. Going further, debt
cancellation would increase funds needed to mitigate
COVID-19’s long-term health and socioeconomic effects.
With compound health crises worldwide, UN human
itarian appeals face record shortfalls. The Biden admin
istration could build on the tradition of US humanitarian
leadership by funding at least 40%—the USA’s share of
high-income country gross national income14—of UN and
WFP appeals.
The USA has developed innovative global health
policies, which have languished under President Trump.
The incoming administration should restore US Centers
for Disease Control and Prevention (CDC) funding for
surveillance, data analysis, and health worker training
in lower-income countries. CDC’s China office, for
example, was cut from 47 to 14 staff under the Trump
presidency.15 Overall, US relationships are frayed, not
only with China but also other key allies.
The US Congress should also fund and re-energise the
global health security agenda, designed to strengthen
and evaluate national health-system capacities globally.
Rectifying President Trump’s damaging decisions,
we urge the Biden administration to re-establish the
White House National Security Council Directorate for
2

Global Health Security and Biodefense and relaunch
the PREDICT virus identification and tracking project.
The incoming administration should also fully replenish
the US Strategic National Stockpile of medical supplies to
prepare for the next health emergency.
The COVID-19 pandemic has underscored the impor
tance of therapeutic countermeasures. To accelerate
access to scientific advances, the incoming administration
will need to increase domestic research and development
funding by at least $1 billion annually, as the National
Academy of Medicine has recommended.16 Globally, the
USA could offer increased support to the Coalition for
Epidemic Preparedness Innovations (CEPI), which funds
platform technologies to rapidly respond to high priority
infectious disease threats. Furthermore, President-elect
Biden should break with previous administrations by
encouraging liberal use of Trade-Related Aspects of
Intellectual Property Rights (TRIPS) flexibilities and avoid
TRIPS-plus trade agreements, which make essential
medicines unaffordable.17
Beyond COVID-19, the world faces life-threatening
challenges, with antimicrobial resistance and the climate
crisis, among the most urgent. Antimicrobial resistance
threatens our ability to treat common infections. The
Biden admin
istration should enhance stewardship of
antimicrobials, regulating agricultural and medical use,
while incentivising pharmaceutical and biotech companies
to develop new antimicrobials and supporting multilateral
efforts to confront antimicrobial resistance.
Climate change adversely affects social and environ
mental determinants of health, including clean air, safe
drinking water, food, and secure shelter.18 Presidentelect Biden plans to rejoin the Paris Agreement on
climate change,19 working with partners to regulate
greenhouse gas emissions, while creating economic
incentives for green technologies. Environmental
stewardship and advancing planetary health should be
priorities for the incoming administration.
Our proposed Biden action agenda is undoubtedly
ambitious, but will reap huge benefits. COVID-19 has
shown that US interests are inextricably tied to global
health security. New disease outbreaks anywhere pose
threats everywhere. Healthier and safer populations
are more stable and economically productive. This
is the time to revitalise US global health leadership,
after a ruinous retreat from global solidarity under
the Trump administration. International cooperation
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on the compound crises of COVID-19 could become a
model for tackling other existential global hazards. Out
of a crisis comes opportunities to build a safer, healthier,
and more just world.
LOG is Director of the WHO Collaborating Centre on National and Global Health
Law. MAH serves on the GAVI Board and the Scientific Advisory Council of the
Bill & Melinda Gates Foundation, chairs the Joint Coordinating Group of CEPI,
is Co-chair of the WHO Expert Advisory Committee on Human Genome Editing,
and receives an honorarium for the Bill & Melinda Gates Foundation work;
the other activities are unpaid. BRB reports personal fees from The New England
Journal of Medicine, outside the area of work discussed here. DES, JPK, BKR,
and MAW declare no competing interests.
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